Letter

Community acquired pneumonia

Antibiotic coverage is atypical: evidence from randomised trials

BMJ 2007; 335 doi: 10.1136/bmj.39409.402894.BE (Published 29 November 2007)
Cite this as: BMJ 2007;335:1109.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Leonard Leibovici, head, Department of Medicine E,
  2. Eyal Robenshtock, senior physician, Department of Medicine E,
  3. Mical Paul, consultant, Infectious Diseases Unit
  1. Beilinson Campus, Rabin Medical Centre, Petah-Tiqva, Israel
  1. leibovic{at}post.tau.ac.il

    Bjerre quotes an observational study to support the addition of antibiotics that cover atypical pathogens to the treatment of patients with community acquired pneumonia.1 The results of randomised controlled trials dealing with this question were amassed in two recent systematic reviews and meta-analyses (one published in the BMJ …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular